Literature DB >> 28509125

A case of PR3-ANCA-positive anti-GBM disease associated with intrarenal arteritis and thrombotic microangiopathy.

Shun Manabe1, Mayuko Banno1, Marie Nakano1, Teruhiro Fujii1, Yukio Kakuta2, Kosaku Nitta3, Michiyasu Hatano1.   

Abstract

Coexistence of anti-glomerular basement membrane (anti-GBM) disease with anti-neutrophil cytoplasmic antibody (ANCA) is occasionally reported and termed "double positive" disease. Interestingly, the majority of "double positive" ANCA is myeloperoxidase (MPO)-ANCA, and some of the MPO-ANCA-positive cases reveal intrarenal arteritis indicating an ANCA-associated renal lesion. In contrast, proteinase 3 (PR3)-ANCA-positive "double positive" disease had rarely been reported, and as far as we know, none of the cases showed intrarenal arteritis. Herein, we report a case of PR3-ANCA-positive "double positive" anti-GBM disease presenting with pulmonary-renal syndrome and hemolytic uremic syndrome. The kidney biopsy showed crescentic glomerulonephritis, intrarenal arteritis, and thrombotic microangiopathy. This case newly describes PR3-ANCA-associated intrarenal arteritis in "double positive" anti-GBM disease.

Entities:  

Keywords:  Anti-glomerular basement membrane disease; Double positive disease; Intrarenal arteritis; Proteinase 3-anti-neutrophil cytoplasmic antibody; Pulmonary-renal syndrome; Thrombotic microangiopathy

Year:  2016        PMID: 28509125      PMCID: PMC5438805          DOI: 10.1007/s13730-016-0240-3

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  30 in total

Review 1.  Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.

Authors:  Abraham Rutgers; Marjan Slot; Pieter van Paassen; Peter van Breda Vriesman; Peter Heeringa; Jan Willem Cohen Tervaert
Journal:  Am J Kidney Dis       Date:  2005-08       Impact factor: 8.860

2.  Development of anti-glomerular basement membrane disease after remission from perinuclear ANCA-associated glomerulonephritis in a patient with HLA susceptibility.

Authors:  Kate O'Connor; David Fulcher; Richard K S Phoon
Journal:  Am J Kidney Dis       Date:  2009-09-06       Impact factor: 8.860

3.  Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institution.

Authors:  Kimimasa Nakabayashi; Yasunori Fujioka; Yoshihiro Arimura; Toshihito Fukuoka; Tomohumi Marumo; Michiru Umino; Yasushi Kamiya; Takahiro Okai; Shigeru Tsurumaki; Toshihiko Nagasawa; Akira Yamada
Journal:  Clin Exp Nephrol       Date:  2011-04-09       Impact factor: 2.801

4.  Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.

Authors:  Alenka Vizjak; Tomaz Rott; Mira Koselj-Kajtna; Blaz Rozman; Stasa Kaplan-Pavlovcic; Dusan Ferluga
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

5.  Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.

Authors:  Jelka Lindic; Alenka Vizjak; Dusan Ferluga; Damjan Kovac; Andreja Ales; Radoslav Kveder; Rafael Ponikvar; Andrej Bren
Journal:  Ther Apher Dial       Date:  2009-08       Impact factor: 1.762

6.  Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis.

Authors:  Stephen Paul McAdoo; Angela Hall; Jeremy Levy; Alan D Salama; Charles D Pusey
Journal:  J Clin Rheumatol       Date:  2012-10       Impact factor: 3.517

7.  Concurrent and discrete clinicopathological presentations of Wegener granulomatosis and anti-glomerular basement membrane disease.

Authors:  Stephen Clyne; Candice Frederick; Frederick Arndt; Julia Lewis; Agnes B Fogo
Journal:  Am J Kidney Dis       Date:  2009-07-04       Impact factor: 8.860

8.  Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases.

Authors:  Tomomi Matsuyama; Masataka Kuwana; Masanori Matsumoto; Ayami Isonishi; Shigeko Inokuma; Yoshihiro Fujimura
Journal:  Thromb Haemost       Date:  2009-08       Impact factor: 5.249

9.  The patient with C-ANCA/PR3-ANCA-positive crescentic pauci-immune glomerulonephritis and recurrence of nephritic sediment.

Authors:  Martin Andrassy; Jeanne Sis; Rüdiger Waldherr; Martin Zeier; Vedat Schwenger
Journal:  Nephrol Dial Transplant       Date:  2008-03-01       Impact factor: 5.992

10.  Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis.

Authors:  Jacques Serratrice; Laurent Chiche; Bertrand Dussol; Brigitte Granel; Laurent Daniel; Sophie Jego-Desplat; Patrick Disdier; Laure Swiader; Yvon Berland; Pierre-Jean Weiller
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.